The influence of recommendations related to cardiovascular drugs issued by agency for health technology assessment in poland (aotm) in years 2005-2012 for the reimbursement decisions
Abstract
Authors
G. Ofierska-Sujkowska K. Jagodzinska-Kalinowska W. Matusewicz